Development of the General surgery prioritisation tool implemented in New Zealand in 2018.


Journal

Health policy (Amsterdam, Netherlands)
ISSN: 1872-6054
Titre abrégé: Health Policy
Pays: Ireland
ID NLM: 8409431

Informations de publication

Date de publication:
10 2020
Historique:
received: 30 10 2019
revised: 05 07 2020
accepted: 10 07 2020
pubmed: 23 8 2020
medline: 29 7 2021
entrez: 23 8 2020
Statut: ppublish

Résumé

Patients waitlisted for elective general surgery in New Zealand used to be prioritised by multiple tools that were inconsistent, did not reflect clinical judgement and were not validated. We describe the development and implementation of a national prioritisation tool for elective general surgery in New Zealand, which could be applicable to other OECD countries. The tool aims to achieve equity of access, transparency, reliability and should be aligned with clinical judgement. The General Surgery Prioritisation Tool Working Group commenced development of a prioritisation tool in 2014 which showed strong correlation with clinical judgement (r = 0.89), excellent test-retest reliability (r = 0.98) and significantly lower variability (p < 0.001). Preliminary findings showed no significant difference in scores attributable to age, gender or ethnicity. General Surgeons were in favour of the tool criteria and agreed on the importance of prioritisation; however a minority opposed its introduction. Health organisations and general practitioner groups were in favour, however, along with many surgeons, expressed apprehensions regarding subjectivity, manipulation, equity of access and degree of benefit. Despite reservations, the majority of stakeholders were supportive and through collaboration between clinicians and the government, the tool was implemented in 2018 in New Zealand. Overall, the prioritisation tool is a reliable method of assessing priority, demonstrating transparency and reflecting clinical judgement, with equity of access to be further assessed by evaluation in clinical practice.

Identifiants

pubmed: 32826089
pii: S0168-8510(20)30200-1
doi: 10.1016/j.healthpol.2020.07.018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1043-1049

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There are no conflicts of interest to disclose.

Auteurs

Gajan Srikumar (G)

Department of General Surgery, Middlemore Hospital, University of Auckland, 100 Hospital Road, Otahuhu, Auckland 2025, New Zealand. Electronic address: gajan.srikumar@gmail.com.

Tim Eglinton (T)

Department of General Surgery, Christchurch Hospital, University of Otago, Christchurch, New Zealand. Electronic address: Tim.Eglinton@cdhb.health.nz.

Andrew D MacCormick (AD)

Department of General Surgery, Middlemore Hospital, University of Auckland, 100 Hospital Road, Otahuhu, Auckland 2025, New Zealand. Electronic address: Andrew.Maccormick@middlemore.co.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH